Drug or technology

Enicepatide

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 14, 2026 · PHASE 3 TRIAL

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

ClinicalTrials.gov

This is an active Phase 3 registry record with no reported results; the study is still recruiting and outcome data are not yet available.

PreliminaryEnicepatide Obesity Or Overweight NCT07351045

Reported

Planned sample size2000

Primary outcome measurePercent change from baseline in body weight…

Study phasePhase 3

AUG 7, 2026 · PHASE 2 TRIAL

A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight

ClinicalTrials.gov

This is a planned Phase 2 dose-finding trial with no results yet reported; registration documents the study design and population but carries no efficacy or safety data.

PreliminaryPetrelintide Enicepatide-matching Placebo NCT07589686

Reported

Planned enrollment486

PhasePhase 2

Primary endpointPercentage change in body weight between Ar…